A Mansonone Derivative Coupled with Monoclonal Antibody 4D5-Modified Chitosan Inhibit AKR1C3 to Treat Castration-Resistant Prostate Cancer

A Mansonone Derivative Coupled with Monoclonal Antibody 4D5-Modified Chitosan Inhibit AKR1C3 to Treat Castration-Resistant Prostate Cancer

Meng Zhou,1,* Xiaoyu Wang,1,* Jie Xia,2 Yating Cheng,1 Lichun Xiao,1 Yu Bei,3 Jianzhong Tang,3 Yadong Huang,1,3 Qi Xiang,1,3 Shiliang Huang2 1Institute of Biomedicine and Guangdong Provincial Key Laboratory of Bioengineering Medicine, Jinan University, Guangzhou 510632, People’s Republic o...

Full description

Bibliographic Details
Main Authors: Zhou M, Wang X, Xia J, Cheng Y, Xiao L, Bei Y, Tang J, Huang Y, Xiang Q, Huang S
Format: Article
Language:English
Published: Dove Medical Press 2020-05-01
Series:International Journal of Nanomedicine
Subjects:
mansonone derivative
conjugate of her2 monoclonal antibody extracellular fragment 4d5
castration-resistant prostate cancer
Online Access:https://www.dovepress.com/a-mansonone-derivative-coupled-with-monoclonal-antibody-4d5-modified-c-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/a-mansonone-derivative-coupled-with-monoclonal-antibody-4d5-modified-c-peer-reviewed-article-IJN

Similar Items